NPPB and obesity disorder: Overexpressing BNP or genetic/pharmacological cGMP augmentation in several animal models induced adipose tissue browning and lipid oxidation, promoted mitochondrial biogenesis and fat oxidation in skeletal muscle, preventing obesity and glucose intolerance77,79,81.